Workflow
聚乙二醇
icon
Search documents
奥克股份:公司的聚乙二醇产品目前主要应用于医药辅料等领域
Zheng Quan Ri Bao Wang· 2025-09-30 09:15
证券日报网讯奥克股份(300082)9月30日在互动平台回答投资者提问时表示,公司的聚乙二醇产品目 前主要应用于医药辅料、原料药、锂电新能源及日化等领域,PEO材料尚在研究开发中,如有需要披露 的信息,公司将依法合规披露。 ...
奥克股份:公司聚乙二醇主要应用于医药辅料、原料药、锂电新能源及日化等领域
Mei Ri Jing Ji Xin Wen· 2025-09-30 01:31
奥克股份(300082.SZ)9月30日在投资者互动平台表示,公司始终密切关注聚乙二醇在各领域的应用动 态。目前公司聚乙二醇主要应用于医药辅料、原料药、锂电新能源及日化等领域。 (文章来源:每日经济新闻) 每经AI快讯,有投资者在投资者互动平台提问:目前高端纤维面料中加入聚乙二醇的越来越多,体感 舒适且价格高昂,公司有关注此用途并与面料生产商探讨合作吗? ...
奥克股份涨2.01%,成交额4249.23万元,主力资金净流入81.29万元
Xin Lang Zheng Quan· 2025-09-24 05:16
Company Overview - Aoke Co., Ltd. is located in Liao Yang, Liaoning Province, and was established on January 1, 2000. The company was listed on May 20, 2010. Its main business involves the research, development, production, and sales of ethylene oxide, ethylene-derived green low-carbon fine chemical high-end new materials [1][2]. Financial Performance - For the first half of 2025, Aoke Co., Ltd. achieved operating revenue of 2.042 billion yuan, representing a year-on-year growth of 11.21%. The net profit attributable to the parent company was 1.3035 million yuan, showing a significant year-on-year increase of 101.29% [2]. - Since its A-share listing, Aoke Co., Ltd. has distributed a total of 1.453 billion yuan in dividends. However, there have been no dividend distributions in the past three years [3]. Stock Performance - As of September 24, Aoke Co., Ltd.'s stock price increased by 2.01%, reaching 7.60 yuan per share, with a total market capitalization of 5.169 billion yuan. The stock has risen by 21.21% year-to-date, but has seen a decline of 5.12% over the last five trading days [1]. - The stock has been featured on the "Dragon and Tiger List" once this year, with the most recent appearance on June 5, where it recorded a net purchase of 86.6737 million yuan [1]. Shareholder Information - As of June 30, the number of shareholders for Aoke Co., Ltd. was 35,600, an increase of 11.34% from the previous period. The average number of tradable shares per shareholder decreased by 10.18% to 19,075 shares [2]. Business Segments - The main revenue composition of Aoke Co., Ltd. includes: 65.11% from polyether monomers, 20.58% from polyethylene glycol, 13.99% from fatty alcohol ethers, and 0.31% from other sources [1].
奥克股份(300082.SZ):PEO材料尚在研究开发中,暂未向固态电池厂商供应固态电解质材料
Ge Long Hui· 2025-09-22 07:30
Core Viewpoint - The company is actively expanding the applications of its polyethylene glycol (PEG) products in various sectors, including pharmaceuticals, lithium battery new energy, and daily chemicals, while continuing research and development for other uses [1] Group 1: Product Applications - The company's PEG products are primarily used in pharmaceutical excipients, active pharmaceutical ingredients, lithium battery new energy, and daily chemicals [1] - The company is currently supplying PEG to Fulin Precision for use in lithium battery cathode materials [1] Group 2: Research and Development - The company is still in the research and development phase for PEG materials and has not yet supplied solid electrolyte materials to solid-state battery manufacturers [1] - The company is continuously exploring additional applications for polyethylene glycol [1]
奥克股份9月17日获融资买入483.60万元,融资余额1.08亿元
Xin Lang Cai Jing· 2025-09-18 01:32
Group 1 - The core viewpoint of the news is that Aok Chemical Co., Ltd. has shown fluctuations in its stock performance and financing activities, with a notable increase in revenue and profit in the first half of 2025 [1][2]. Group 2 - On September 17, Aok shares fell by 0.62%, with a trading volume of 68.39 million yuan. The financing buy amount was 4.84 million yuan, while the financing repayment was 6.15 million yuan, resulting in a net financing buy of -1.32 million yuan [1]. - As of September 17, the total balance of margin trading for Aok shares was 108 million yuan, accounting for 1.98% of the circulating market value, which is above the 80th percentile level over the past year [1]. - The company has not engaged in any short selling activities on September 17, with a short selling balance of 0.00 shares, indicating a high level of short selling activity over the past year [1]. Group 3 - As of June 30, the number of shareholders of Aok shares was 35,600, an increase of 11.34% compared to the previous period. The average circulating shares per person decreased by 10.18% to 19,075 shares [2]. - For the first half of 2025, Aok achieved an operating income of 2.04 billion yuan, representing a year-on-year growth of 11.21%. The net profit attributable to the parent company was 1.30 million yuan, with a significant year-on-year increase of 101.29% [2]. Group 4 - Since its A-share listing, Aok has distributed a total of 1.45 billion yuan in dividends, with no dividends paid in the last three years [3].
奥克股份:公司始终密切关注聚乙二醇在各领域的应用动态
Zheng Quan Ri Bao Wang· 2025-09-15 08:41
证券日报网讯奥克股份(300082)9月15日在互动平台回答投资者提问时表示,公司始终密切关注聚乙 二醇在各领域的应用动态。目前,产品在医药原料药、锂电新能源及日化等领域已有规模化应用。若有 新领域、新应用等的重大突破且符合披露标准,公司将依法依规及时披露。 ...
奥克股份:在医药领域如丹参滴丸、速效救心丸、注射剂等方面都有聚乙二醇的应用
Core Viewpoint - Aok shares highlighted the non-toxic and non-irritating properties of polyethylene glycol (PEG) products, emphasizing their wide applications in various industries, including pharmaceuticals and daily chemicals [1] Group 1: Product Characteristics - PEG products are characterized by good water solubility and compatibility with many organic components [1] - The products exhibit excellent lubricating, moisturizing, dispersing, adhesive, antistatic, and softening properties [1] Group 2: Industry Applications - Aok's PEG products have achieved large-scale applications in pharmaceutical excipients, raw materials for drugs, lithium battery new energy, and daily chemicals [1] - In the pharmaceutical sector, PEG is utilized in products such as Danshen dripping pills, rapid heart rescue pills, and injectables [1]
奥克股份:目前公司聚乙二醇主要应用于医药辅料、原料药、锂电新能源及日化等领域
Zheng Quan Ri Bao Wang· 2025-09-12 09:45
证券日报网讯奥克股份(300082)9月12日在互动平台回答投资者提问时表示,目前公司聚乙二醇主要 应用于医药辅料、原料药、锂电新能源及日化等领域,对于在其他领域的应用,尚处于应用探索阶段, 暂无可披露的信息。 ...
奥克股份:目前公司的聚乙二醇产品在医药辅料、原料药、锂电新能源及日化等领域已有规模化的应用
Mei Ri Jing Ji Xin Wen· 2025-09-12 01:28
Core Viewpoint - The company, Aok Holdings (300082.SZ), emphasizes the versatility and safety of its polyethylene glycol products, highlighting their wide application in various industries, including pharmaceuticals and lithium battery new energy [1][3]. Group 1: Product Characteristics - Polyethylene glycol products are non-toxic, non-irritating, and possess good water solubility [1]. - These products exhibit excellent compatibility with many organic components, providing superior lubricating, moisturizing, dispersing, adhesive, antistatic, and softening properties [1]. Group 2: Application Areas - The company's polyethylene glycol products have already been scaled for use in pharmaceuticals, raw materials, lithium battery new energy, and daily chemicals [1]. - In the pharmaceutical sector, polyethylene glycol is utilized in various applications, including Danshen dripping pills, rapid heart rescue pills, and injectables [1].
奥克股份8月29日获融资买入1166.01万元,融资余额1.17亿元
Xin Lang Cai Jing· 2025-09-01 02:16
Group 1 - On August 29, Aok Chemical shares increased by 1.57%, with a trading volume of 98.54 million yuan [1] - The financing data for Aok Chemical on the same day showed a financing purchase amount of 11.66 million yuan, a repayment of 7.21 million yuan, resulting in a net financing purchase of 4.45 million yuan [1] - As of August 29, the total balance of margin trading for Aok Chemical was 117 million yuan, which accounts for 2.21% of its market capitalization [1] Group 2 - As of June 30, the number of shareholders for Aok Chemical was 35,600, an increase of 11.34% compared to the previous period [2] - The average circulating shares per person decreased by 10.18% to 19,075 shares [2] - For the first half of 2025, Aok Chemical reported operating revenue of 2.04 billion yuan, a year-on-year increase of 11.21%, and a net profit attributable to shareholders of 1.30 million yuan, up 101.29% year-on-year [2] Group 3 - Since its A-share listing, Aok Chemical has distributed a total of 1.45 billion yuan in dividends, with no dividends paid in the last three years [3]